2026 QUESTIONS WITH SOLUTIONS GRADED
A+
◉ What was learned from the early methadone research?
A. Methadone treatment was corrective, but patients can't taper
from it
B. Patients experienced intoxication from methadone similar to
heroin
C. Patients experienced ceiling agonist effects therefore did not have
blockade from the short- acting opioids
D. Methadone treatment reduced death, crime days, decreased HIV
seroconversion, Intravenous drug use, and increased social function.
Answer: D. Methadone treatment reduced death, crime days,
decreased HIV seroconversion, Intravenous drug use, and increased
social function
◉ Increasing mortality has been seen in the US due to the opioid
epidemic compared to six other countries in which group?
A. Young adults
B. Middle aged white men
,C. African Americans
D. Middle aged white women. Answer: B. Middle aged white men
◉ Each of the following is a means by which a prescriber could
qualify to obtain the waiver needed to engage in office-based
treatment of opioid addiction except:
A. Board-certified in Addiction Psychiatry
B. At least 100 hours in addiction medicine practice that has been
reviewed and approved by SAMHSA
C. Completed approved 8-hour training offered by a group named in
DATA 2000
D. Completed 8 hours of training offered by the American Medical
Association
E. NP or PA who completed the 24 hours of addiction curriculum
training. Answer: B. At least 100 hours in addiction medicine
practice that has been reviewed and approved by SAMHSA
◉ A provider completes the required training and is eligible for the
waiver to offer office-based treatment of opioid dependence. The
provider practices in a community with epidemic opioid addiction
and has 38 opioid-dependent individuals who have inquired about
this treatment and asked to be treated when the provider starts the
buprenorphine/naloxone practice. Which of the following is the
appropriate course of action:
, A. Completion of the course and submission of the Notification of
Intent form is sufficient to start practice.
B. The provider needs to wait up to 45 days to receive their waiver
and treat up to 30 patients at one time.
C. The provider can apply for an extended waiver to 100 upon
receipt of waiver.
D. The provider may treat these patients with
buprenorphine/naloxone off-label.
E. The provider may treat all of these individuals by completing an
additional notification to the DEA of the urgent need in th. Answer:
B. The provider needs to wait up to 45 days to receive their waiver
and treat up to 30 patients at one time.
◉ The Drug Addiction Treatment Act of 2000 (DATA 2000) allows
waivered providers to provide Office Based Opioid Treatment which
includes all except:
A. FDA approved medications for maintenance or detoxification
B. Medications in schedules III, IV, or V
C. Buprenorphine or Buprenorphine/naloxone
D. Methadone. Answer: D. Methadone